← Back to Search

Behavioural Intervention

rTMS for Dystonia

N/A
Waitlist Available
Led By Cathrin Buetefisch, MD, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
If you are treated with Botulinum toxin, the testing should be done at least 3 months after your last Botulinum toxin injections.
No intake of CNS active drugs that may interfere with the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 weeks (2 visits)
Awards & highlights

Study Summary

This trial is testing whether transcranial magnetic stimulation (TMS) can help people with dystonia, a disease where muscles in the affected body part are abnormally active.

Eligible Conditions
  • Dystonia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
If you have received Botulinum toxin injections, you must wait at least three months before participating in the study.
Select...
You are not taking any medication that affects the central nervous system and could interfere with the study.
Select...
You have a condition called task-specific dystonia, which only affects one hand and has been present since the symptoms began.
Select...
You can complete a specific task.
Select...
You don't have any other medical condition that can affect your nervous system and interfere with the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 weeks (2 visits)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 weeks (2 visits) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy of TMS on task-specific focal hand dystonia

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: rTMSActive Control1 Intervention
rTMS condition, rTMS will be applied at 0.1-0.5 Hz frequency at a subthreshold intensity
Group II: rTMS shamPlacebo Group1 Intervention
Placebo condition will use a sham coil and apply a very small magnetic stimulus

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,627 Previous Clinical Trials
2,560,750 Total Patients Enrolled
5 Trials studying Dystonia
3,690 Patients Enrolled for Dystonia
Cathrin Buetefisch, MD, PhDPrincipal InvestigatorEmory University
3 Previous Clinical Trials
168 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current size of this research program's participant pool?

"Affirmative. The information available on clinicaltrials.gov implies that this medical trial is actively searching for participants, having been first posted on February 1st 2013 and recently updated January 24th 2022. 15 patients are needed from a single site to complete the study's requirements."

Answered by AI

Is enrollment still available for this experiment?

"Clinicaltrials.gov has indicated that this research study is still recruiting participants, with the original posting date being February 1st 2013 and the last update occurring on January 24th 2022."

Answered by AI

Is the age limit for participation in this research trial greater than 30?

"The eligibility for this medical trial requires that patients are aged 18 to 80."

Answered by AI

Do I qualify to participate in this research study?

"Aspiring enrollees in the trial must have a diagnosis of dystonia and be between 18 to 80 years old. This clinical study is limited to 15 participants."

Answered by AI
~1 spots leftby Mar 2025